COMMISSION IMPLEMENTING REGULATION
(EU) No 94/2014
of 31 January 2014
approving iodine, including polyvinylpyrrolidone iodine, as an existing active substance for use in biocidal products for product-types 1, 3, 4 and 22
(Text with EEA relevance)
Article 1
Article 2
ANNEX
Common Name |
IUPAC Name Identification Numbers |
Minimum degree of purity of the active substance(1) |
Date of approval |
Expiry date of approval |
Product type |
Specific conditions(2) |
Iodine (including polyvinylpyrrolidone iodine) |
IUPAC Name: Iodine EC No: 231-442-4 CAS No: 7553-56-2 IUPAC Name: Polyvinylpyrrolidone iodine EC No: n.a., CAS No: 25655-41-8 |
995 g/kg of iodine For polyvinylpyrrolidone iodine: the iodine content shall have a purity of 995 g/kg |
1 September 2015 |
31 August 2025 |
1 |
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. |
3 |
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. Authorisations are subject to the following conditions: For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council(3) or Regulation (EC) No 396/2005 of the European Parliament and of the Council(4) shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded. |
|||||
4 |
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. Authorisations are subject to the following conditions:
|
|||||
22 |
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not adressed in the Union level risk assessment of the active substance. Authorisations are subject to the following condition: For professional users, safe operational procedures and appropriate organizational measures shall be established. Where exposure cannot be reduced to an acceptable level by other means, products shall be used with appropriate personal protective equipment. |